Henry Butt

Henry Butt, MSc, PhD, is the Director of Bioscreen (a laboratory specializing in fecal microbial analysis) and a researcher in Newcastle, Australia.

Books

 * 2014, Chapter Five in Advances in Clinical Chemistry, Vol. 66, published by Elsevier; "Metabolism in Chronic Fatigue Syndrome," by Christopher W. Armstrong,  Neil R. McGregor, Henry L. Butt, and Paul R. Gooley

Notable studies

 * 1996, Preliminary determination of the association between symptom expression and urinary metabolites in subjects with chronic fatigue syndrome
 * 1996, Preliminary determination of a molecular basis of chronic fatigue syndrome
 * 1997, A Preliminary Assessment of the Association of SCL-90-R Psychological Inventory Responses with Changes in Urinary Metabolites in Patients with Chronic Fatigue Syndrome
 * 1998, Immunological and Haematological Parameters in Patients with Chronic Fatigue Syndrome (Abstract)
 * 2000, Blood parameters indicative of oxidative stress are associated with symptom expression in chronic fatigue syndrome
 * 2000, Erythrocyte Morphology in Rheumatoid Arthritis and Chronic Fatigue Syndrome: A Preliminary Study
 * 2000, Investigation of Erythrocyte Oxidative Damage in Rheumatoid Arthritis and Chronic Fatigue Syndrome
 * 2009, Increased D-Lactic Acid Intestinal Bacteria in Patients with Chronic Fatigue Syndrome
 * 2015, Sleep quality and the treatment of intestinal microbiota imbalance in Chronic Fatigue Syndrome: A pilot study (Jackson ML, Henry Butt, Ball M, Lewis DP, Bruck D)
 * 2015, Metabolic profiling reveals anomalous energy metabolism and oxidative stress pathways in chronic fatigue syndrome patients
 * 2016, Widespread pain and altered renal function in ME/CFS patients
 * 2016, Support for the Microgenderome: Associations in a Human Clinical Population (Full Text)
 * 2017, Examining clinical similarities between myalgic encephalomyelitis/chronic fatigue syndrome and d-lactic acidosis: a systematic review (Full Text)
 * 2017, The association of fecal microbiota and fecal, blood serum and urine metabolites in myalgic encephalomyelitis/chronic fatigue syndrome
 * 2018, Open-label pilot for treatment targeting gut dysbiosis in myalgic encephalomyelitis/chronic fatigue syndrome: neuropsychological symptoms and sex comparisons (Full Text) (Correction)
 * 2012, NMR metabolic profiling of serum identifies amino acid disturbances in chronic fatigue syndrome

Clinic location
Newcastle, Australia.

Online presence

 * PubMed - Henry Butt

Learn more

 * 2000, Newcastle Team Lecture - Dr Henry Butt
 * 2010, Gut Inflammation in Chronic Fatigue Syndrome